Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3100 results found
2026 ∙ Danysz, M. De Aguiar, R. C. Pindolia, H. Stuart, B. Spensley, K. Ashmore, E. Frumento, N. Haouidji-Javaux, N. Hutchinson, C. Iles, R. Lau, S. Rolt, J. Uwenedi, G. Wagg, H. Barnes, E. Lim, S. H. Richter, A. Willicombe, M.
Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies
Adults COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2026 ∙ Yang, J. W. Jiang, J.
Association between varicella-zoster virus and Alzheimer's disease: A systematic review and meta-analysis of comprehensive evidence from infection, treatment to prevention
All age groups Herpes zoster Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Nguyen, A. T. Duckworth, E. D. Li, R. A. Adam, T. H. Galiano, R. D.
Cervical Cancer Prevention and Treatment Disparities Among Native Hawaiian and Pacific Islanders: A Systematic Review and Meta-Analysis
All age groups Human papillomavirus (HPV) Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Suleman, D. B. Folorunsho, S.
Cervical cancer research disparities among African immigrant women in the United States: A systematic review
Americas United States of America Adults Older adults Human papillomavirus (HPV) Coverage Acceptance Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Hayford, K. Tort, M. J. Huang, L. Forbes, C. Pustulka, I. Chapman, R. Theilacker, C.
Clinical effectiveness and impact of 13-valent pneumococcal conjugate vaccines in preventing invasive pneumococcal disease among children with risk conditions: A systematic literature review
Newborn Children Adolescents Pneumococcal disease Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Omam, L. A. Jarman, E. Malik, F. Kamwa, V. Mba, C. M.
Containment and response strategies for mpox outbreaks: a systematic review
All age groups Mpox Efficacy/effectiveness Administration Coverage Logistics Ethical issues
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Faghir-Ganji, M. Abdolmohammadi, N. Ansari-Moghaddam, A. Askari, S. Eshrati, B.
COVID-19 vaccination and stroke risk: A systematic review and meta-analysis of ischemic and hemorrhagic events
All age groups COVID-19 Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Lotfi, M. Kaderali, L.
Data-driven strategies for model-informed decision-making during the COVID-19 pandemic: a systematic review
All age groups COVID-19 Modeling
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Yegorov, S. Patel, O. D. Sharma, H. Khan, T. Gupta, R. Yao, M. Sritharan, A. Silverman, N. Pullenayegum, E. Miller, M. S. Loeb, M.
Effectiveness of influenza vaccination to prevent severe disease: a systematic review and meta-analysis of test-negative design studies
All age groups Influenza Efficacy/effectiveness Administration
Methodological quality (AMSTAR 2):
Critically low
2026 ∙ Alkhidir, M. Sridharan, K.
Efficacy and Safety of mRNA-Based COVID-19 Vaccines in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
Loading...